Utica announced the closing of a $3 million Capital Lease for a Southeast-based pharmaceutical manufacturer specializing in Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF). Secured by manufacturing and analytical equipment, the lease marks the second schedule of funding provided to this customer.

The financing supports the company’s ongoing expansion efforts, following the recent acquisition of additional production facilities. Licensed to produce, package and market both prescription and over-the-counter medications, the manufacturer will use the proceeds to enhance operational capacity and strengthen its working-capital position as it scales production for new and existing partners.

Utica’s continued partnership reflects its commitment to providing flexible, asset-based financing solutions that empower healthcare and life sciences companies to grow with confidence.

Utica Equipment Finance provides companies across various industries with collateral and credit-based equipment financing products ranging from $1 million to $50 million.